loading
GPP-100
GOLDSITE
Availability: | |
---|---|
Nephelometry has become the main method for performing protein tests, measuring the turbidity of a sample to determine the level of analyte; the difference is that immunoturbidimetric tests measure the absorbance of light by the sample whereas nephelometric tests measure the light scattered at a fixed angle.
GPP-100 Specific Protein Analyzer testing provides numerous advantages, most notably it offers lower laboratory costs, lower consumable costs, no need highly trained personnel, and are able to perform a wide range of assays.
GPP-100 is a routine clinical analysers, thus offering test consolidation; consolidation of tests on one single platform offers improved laboratory efficiency, versatility, rapid testing and cost-savings.
Nephelometry has become the main method for performing protein tests, measuring the turbidity of a sample to determine the level of analyte; the difference is that immunoturbidimetric tests measure the absorbance of light by the sample whereas nephelometric tests measure the light scattered at a fixed angle.
GPP-100 Specific Protein Analyzer testing provides numerous advantages, most notably it offers lower laboratory costs, lower consumable costs, no need highly trained personnel, and are able to perform a wide range of assays.
GPP-100 is a routine clinical analysers, thus offering test consolidation; consolidation of tests on one single platform offers improved laboratory efficiency, versatility, rapid testing and cost-savings.
Assay | Linear Range | Sample Type | Categories |
HbA1c | 2.8% –15.5% | Blood | Diabetes |
IgA | 0.23 – 5.10g/L | Blood/Plasma/Serum | Immune Disease |
IgG | 1.8 – 26.0 g/L | Blood/Plasma/Serum | |
IgM | 0.18 – 4.60 g/L | Plasma/Serum | |
C3 | 0.19 – 4.70 g/L | Plasma/Serum | |
C4 | 0.06 – 2.20 g/L | Plasma/Serum | |
KAP | 0.88 – 12.20 g/L | Serum | |
LAM | 0.65 – 7.10 g/L | Serum | |
ASO | 41 – 607 IU/mL | Serum | Rheumatoid Disease |
RF | 20 – 306 IU/mL | Serum | |
CCP | 15 – 200 IU/mL | Serum | |
D-Dimer | 0.28 – 15.70mg/L | Plasma | Cardiovascular Disease |
UsCRP | 0.22 – 19.00mg/L | Plasma/Serum | |
LP(a) | 60 – 1200 mg/L | Serum | |
FR-CRP | 0.5 – 380.0 mg/L | Blood/plasma/Serum | Inflammation |
CRP | 1.6 – 152.0 mg/L | Plasma/Serum | |
SAA | 3 – 200 mg/L | Blood/plasma/Serum | |
TRF | 0.25 – 6.10 g/L | Serum | |
Urine IgG | 4 – 100 mg/L | Urine | Kidney Disease |
Urine TRF | 1 – 80 mg/L | Urine | |
A1M | 5 – 200 mg/L | Urine | |
mALB | 9.5 – 230.0 mg/L | Urine | |
CysC | 0.4 – 7.6 mg/L | Plasma/Serum | |
BMG | 0.4 – 13.0 mg/L | Plasma/Serum/Urine |
Assay | Linear Range | Sample Type | Categories |
HbA1c | 2.8% –15.5% | Blood | Diabetes |
IgA | 0.23 – 5.10g/L | Blood/Plasma/Serum | Immune Disease |
IgG | 1.8 – 26.0 g/L | Blood/Plasma/Serum | |
IgM | 0.18 – 4.60 g/L | Plasma/Serum | |
C3 | 0.19 – 4.70 g/L | Plasma/Serum | |
C4 | 0.06 – 2.20 g/L | Plasma/Serum | |
KAP | 0.88 – 12.20 g/L | Serum | |
LAM | 0.65 – 7.10 g/L | Serum | |
ASO | 41 – 607 IU/mL | Serum | Rheumatoid Disease |
RF | 20 – 306 IU/mL | Serum | |
CCP | 15 – 200 IU/mL | Serum | |
D-Dimer | 0.28 – 15.70mg/L | Plasma | Cardiovascular Disease |
UsCRP | 0.22 – 19.00mg/L | Plasma/Serum | |
LP(a) | 60 – 1200 mg/L | Serum | |
FR-CRP | 0.5 – 380.0 mg/L | Blood/plasma/Serum | Inflammation |
CRP | 1.6 – 152.0 mg/L | Plasma/Serum | |
SAA | 3 – 200 mg/L | Blood/plasma/Serum | |
TRF | 0.25 – 6.10 g/L | Serum | |
Urine IgG | 4 – 100 mg/L | Urine | Kidney Disease |
Urine TRF | 1 – 80 mg/L | Urine | |
A1M | 5 – 200 mg/L | Urine | |
mALB | 9.5 – 230.0 mg/L | Urine | |
CysC | 0.4 – 7.6 mg/L | Plasma/Serum | |
BMG | 0.4 – 13.0 mg/L | Plasma/Serum/Urine |